https://doi.org/10.4081/reumatismo.2022.1440

COVID-19 as potential aggravating factor for the natural course of new onset-dermatomyositis

Vol. 74 No. 1 (2022)
Submitted: 15 June 2021
Accepted: 12 March 2022
Published: 3 May 2022
COVID-19, dermatomyositis, inflammatory myopathies, myositis, SARS-CoV-2.
Abstract Views: 2075
PDF: 538
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

M.S.M.S. Faria
Division of Rheumatology, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, SP, Brazil.
S.K. Shinjo
samuel.shinjo@usp.br
https://orcid.org/0000-0002-3682-4517
Division of Rheumatology, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, SP, Brazil.

Borges et al. have recently reported the first case of a dermatomyositis onset in close association with established coronavirus disease 2019 (COVID-19). Similarly, we report a patient who, on the contrary, had COVID-19 following early established dermatomyositis. We report prospectively the outcome of her disease.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC
Lundberg I, Tjärnlund A, Bottai M, et al. 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Arthritis Rheumatol. 2017; 76: 2271-82. DOI: https://doi.org/10.1002/art.40320
Borges NH, Godoy TM, Kahlo BS. Insorgenza di dermatomiosite in stretta associazione con COVID-19 - un primo caso riportato. Rheumatology (Oxford) 2021.[Epub ahead of print].
Ahmed S, Zimba O, Gasparyan AY. COVID-19 e il corso clinico delle manifestazioni reumatiche. Clin Rheumatol. 2021: 1-9.
Raghavan S, Gonakoti S, Asemota IR, Mba B. Un caso di flare di lupus eritematoso sistemico innescato da una grave malattia da coronavirus 2019. J Clin Rheumatol. 2020; 26: 234-36. DOI: https://doi.org/10.1097/RHU.0000000000001531
Lokineni S, Mortezavi M. Miosite necrotizzante a insorgenza ritardata dopo infezione da COVID-19. Eur J Case Rep Int Med. 2021; 8: 002461.
De Souza JM, Hoff LS, Shinjo SK. Terapie a impulsi di immunoglobulina umana per via endovenosa e/o metilprednisolone come possibile strategia treat-to-target nelle miopatie necrotizzanti immunomediate. Rheumatol Int. 2019; 39: 1201-12. DOI: https://doi.org/10.1007/s00296-019-04254-3
De Souza, Miossi R, Shinjo SK. Miopatia necrotizzante associata ad anticorpo anti-signal recognition particle (anti-SRP). Clin Exp Rheumatol. 2017; 35: 766-71.

How to Cite

Faria, M., & Shinjo, S. (2022). COVID-19 as potential aggravating factor for the natural course of new onset-dermatomyositis. Reumatismo, 74(1). https://doi.org/10.4081/reumatismo.2022.1440
Copyright (c) 2022 the Author(s) Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.